Mutation induction in the supF gene of the plasmid pS189 by 7-bromomethylbenz[a]anthracene and 7-bromomethyl-12-methylbenz[a]anthracene was examined. The former compound was substantially more mutagenic than the latter but a much greater proportion of the total mutations were located at mutation hotspots for the 12-methyl derivative. The overall correlation between sites of mutation and sites of polymerase arrest (an Indicator of adduct formation) through the supF gene was poor. Although these bromocompounds should form only a single guanine adduct (unlike dihydrodiol epoxides that form both cis and trans adducts) more than one mutational change was found at a given site, although the predominant base substitution was G-»T for either compound.
Introduction
Polycyclic aromatic hydrocarbon carcinogens are believed to initiate the carcinogenic process through a mutagenic mechanism dependent upon interactions of dihydrodiol epoxide metabolites with DNA [reviewed in (1-3)]. To explore mechanisms through which hydrocarbon-DNA adducts lead to biological effects, we have been studying mutations induced by various hydrocarbon dihydrodiol epoxides (4) (5) (6) (7) in the pS189 shuttle vector containing a target supF gene (8, 9) . Mutational specificities of different dihydrodiol epoxides were similar but not identical, as were their chemical reactions with DNA (10-13). Moreover, as originally reported for acetylaminofluorene adducts (14) , the sites at which mutations occurred most frequently after dihydrodiol epoxide treatment, were not necessarily sites of most extensive adduct formation, as monitored by the sites of polymerase arrest (15, 16) .
The hydrocarbon dihydrodiol epoxides aralkylate the amino groups of the bases in DNA following chemistry first described for 7-bromomethylbenz[a]anthracene (7-BrMeBA*) (17) . In the case of the dihydrodiol epoxides, however, either cis or trans opening of the epoxide can occur leading to a more complex array of products than found for the bromo-compound [reviewed in (18) (19) (20) (21) ]. In the present investigation, we have examined the mutagenic activities in the supF gene of pS189
•Abbreviations: 7-BrMeBA, 7-bromomethylbenz[a]anthracene; 7-BrMel2-MeBA, 7-bromomethyl-12-melhylbenz(a]anthracene. (8, 9 ) of 7-BrMeBA and 7-bromomethyl-12-methylbenz[a]-anthracene (7-BrMel2MeBA) (Figure 1 ) to determine whether the simpler array of products anticipated for these agents would simplify the mutagenic response. We have also monitored the sites in the supF gene at which treatment with these reagents causes polymerase arrest in order to determine whether the polymerase arrest sites and mutagenic hotspots are better correlated for these agents than for the dihydrodiol epoxides.
Materials and methods
Adenovirus-transformed human embryonic kidney cells (Ad293) (22) , Escherichia coli strain MBM 7070 and the shuttle vector pS189 were obtained from Dr Michael Seidman (Otsuka Pharmaceutical, Rockville, MD). 7-BrMeBA and 7-BrMel2MeBA were synthesized as described earlier (23) . Oligonucleotide primers were synthesized on an Applied Biosystems Inc. Model 38OB DNA synthesizer and purified by polyacrylamide gel electrophoresis by Marilyn Powers, PRI/DynCorp Inc., NCI-FCRDC. Primers were labeled with [y-^PJATP (3000 Ci/mmol) using T 4 polynucleotide kinase (24) .
Vector pS189 DNA (150 ug) in 10 mM Tris-HCl/1 mM EDTA, pH 7.6 (127 nl) was treated with 8.40 nmol/ml of 7-BrMeBA or 13.40 nmol/ml of 7-BrMel2MeBA for 1 h at 37°C in the dark. Unbound carcinogen was removed by extracting twice with two volumes of ethyl acetate and twice with two volumes of ethyl ether followed by ethanol precipitation of the DNA.
Primers A 20-mer 5'-AGCAGCAGAT 2 ACGCGCAGA-3', complementary to the sequence at sites 263-281 in the pBR327 origin of replication, was used to sequence mutants. Four 20-mers were used in the polymerase arrest studies. The primer, 5'-A2CGC2TG 2 TATCT3ATAG-3' representing the sequence at sites 740-759 in the pBR327 origin of replication was used to obtain data outside the supF structural gene and three primers, A. 5'-GAGCAG 2 C 2 AG-TA4GCAT-3' representing the sequence at sites 72-91 in the supF sequence, B. 5'-G3TCTGACGCTCA 3 T 2 CT-3' complementary to the sequence at sites 203-222 at the supF/pBR321 origin junction, and C. 5'-CG 2 ACT 4 GA3-GTGATG 2 -3' complementary to the sequence at sites 181-200 at the supF/ pBR327 origin junction, were used to obtain data within the supF structural gene.
Polymerase arrest assay (15) pSI89 DNA (2 p.g) that had been previously treated with carcinogen was denatured with alkali and precipitated with ethanol. The dried pellet was resuspended in water (6.5 uJ) and reaction buffer (2 uj) (200 mM Tris-HCl pH 7.5, 250 mM NaCl, 50 mM MgCy and an equimolar amount of [ n P] end-labeled primer (1.5 \i\) was added. To anneal primer and template, the mixture was heated to 65°C, transferred to a beaker containing water at 65°C and allowed to cool to < 30°C. To this solution 0.1 M dithiothreitol (1.0 uj), water (2.5 ul), and 3.25 U of Sequenase, version 2.0 in 8.8 mM Tris-HCl, 4.4 mM dithiothreitol, 0.44 mg/ml bovine serum albumin, pH 7.5 (2.0 uJ) were added. After mixing, 3.5 Jil was transferred to a tube (prewarmed to 37°C) containing a solution 160 nM in each of the four dNTPs (2_5 |il). This solution was then incubated at 45°C for 5 min. Stop solution (95% formamide, 20 mM EDTA, 0.05% bromophenol blue, 0.05% xylene cyanol FF) (4 (il) coioia HjBr (7-WtoBA) Fig. 1 . Structures of 7-BrMeBA and 7-BrMel2MeBA was then added to terminate the reaction. Electrophoresis of each sample was done on a 6% polyacrylamide gel that was subsequently dried for 2 h at 80°C before exposing to X ray film with an intensifying screen at -70°C. An LKB Bromma Ultroscan XL laser densitometer was used to provide densitometric analysis of each track of an autoradiography film. Integration, using the LKB 2400 Gelscan XL software package, allowed the area under each peak to be expressed as a percentage of the total area under all peaks.
DNA sequencing
The dideoxynucleotide method was used for sequencing pS189 DNA using a Sequenase 2.0 sequencing kit (United States Biochemical Corp., Cleveland, OH). For the sequencing done in conjunction with the polymerase arrest assay, a [
32 P]end-labeled primer was used. However, in sequencing mutant pS189 DNA, an [ 35 S]label was incorporated during primer elongation.
Mutagenesis assay
Ad293 cells (2X10 6 cells/plate) were transfected with 10 ug of either 7-BrMeBA-or 7-BrMel2MeBA-modified pS189 DNA, by calcium phosphate coprecipitation (24) . Plasmid was extracted 48 h later by alkaline lysis (8) and digested with 10 U (3 V/\li) of Dpnl for 1 h at 37°C to remove unreplicated DNA. Extracted DNA was used to transform E.coli MBM 7070 cells by the calcium chloride method (25) . These cells have an amber mutation in the |S-galactosidase gene that can be suppressed by the supF gene product tRNA. Transformed cells were then plated on Luria-Bertani agar plates containing ampicillin (1.25 mg/plate) and overlaid with 2 mg/plate of 5-bromo-4-chloro-3-indolyl P-D-galactoside (X-Gal) and 5 mg/plate of isopropyl p"-Dthiogalactoside (IPTG). Bacteria containing shuttle vector with wild-type supF formed blue colonies, while bacteria containing vector with a mutant supF gene gave pale blue or white colonies. Bacteria from colonies that contained the mutant supF gene were purified by restreaking.
Analysis of mutants
Vector DNA was isolated from bacteria using the Promega Magic Minipreps DNA purification system (Promega Corporation, Madison, WI). A second transformation was then performed to ensure that the mutation originated in the vector rather than the host chromosome and confirmed mutants were sequenced (26) . The x 2 -goodness of fit test (27) was used to determine if the carcinogen-induced point mutations were distributed randomly or nonrandomly over the tRNA gene. A mutation hotspot was defined as a site at which the number of mutations observed was at least 5-fold greater than would be expected for a random distribution of the mutations over the supF structural gene.
Similarly, 7-BrMel2MeBA caused arrests at 100 and 103 on the 5'-3'-strand that were not seen for 7-BrMeBA.
In both the polymerase arrest studies and the mutation studies, a 1.6-fold higher dose of 7-BrMel2MeBA than of 7-BrMeBA was used because it was known that the latter agent reacted more extensively with DNA (28) . Despite the lower dose, 7-BrMeBA was clearly the more potent mutagen, and when mutation frequencies were divided by the doses of each agent used, it appeared that 7-BrMeBA was some 9-fold more potent than 7-BrMel2MeBA as a mutagen in the pS189 system (Table I) . It is also clear from this table that both bromocompounds dramatically increased point mutation frequency (base substitutions and base deletions or insertions) over the
Results and discussion
Three different primers were used to explore polymerase arrest in the supF structural gene of pS 189 exposed either to 7-BrMeBA or to 7-BrMel2MeBA. The results obtained using primer C are shown in Figure 2 . Dideoxynucleotide sequencing lanes from experiments with untreated pS189 DNA are shown on the left-hand side of the gel and control lanes, where DNA was exposed to either Tris/EDTA buffer or solvent (acetone) alone, are on the right. The control lanes show that with untreated DNA, Sequenase version 2 was not arrested within the supF gene and that the 32 P-labeled primer was extended to the higher molecular weight material seen at the top of the gel. In contrast, for DNA exposed to the bromomethyl compounds, many sites of polymerase arrest within the supF gene were evident. Therefore, polymerase arrest was due to the presence of bulky adducts formed by the reaction of the carcinogens with DNA. Figure 3 illustrates the sites and relative intensities of polymerase arrest throughout the supF structural gene after treatment of the pS189 vector with either 7-BrMeBA or 7-BrMel2MeBA. The polymerase arrest findings were similar for the two compounds but some differences were noted. For example, on the 3' to 5' strand, 7-BrMeBA adducts caused a high level of arrest at positions 126 and 142 that were not such significant sites of arrest for the 12-methyl compound whereas in the same strand, 7-BrMel2MeBA caused a much higher level of arrest at site 114 than was seen for 7-BrMeBA. background level. The majority of the induced point mutations were guanine base substitutions (Table II) , in concert with the preferential reactivity of the bromo-compounds with guanine residues in DNA (28) , and the most prevalent mutations were GC-»TA transversions. The major differences noted for the two bromo-compounds were the 5-fold greater preference for mutants derived from the same transfection plate were not scored as independent events because of the possibility that they were in fact siblings (4, 6, 7) . However, recent studies with plasmid pSP189 that contains a 'signature' sequence (29) have indicated that siblings are very rare (29, 30) . We have, therefore, scored all mutants as independent mutational events in the present study.
For both compounds, mutations were not distributed randomly (P < 0.00001) but were concentrated mostly at specific sites, i.e. hotspots. As indicated in the legend to Figure 4 , the assignment of sites for deletion, notably at 172, was arbitrary and these were not considered in the analysis of hotspots for this reason. There were six hotspots for mutation induced by 7-BrMeBA and five induced by 7-BrMel2MeBA. Three hotspots, i.e. sites 109, 127 and 133, were common to both bromo-compounds and, though they did not meet the criteria for a hotspot for both compounds, sites 144, 156, and 164 were prominent mutation targets for both agents. A hotspot unique to 7-BrMeBA was found at site 115 and a hotspot unique to 7-BrMel2MeBA was at site 123. All of these hotspots arose at a GC base pair and, although a single type of base change often predominated at a mutation hotspot, more than one type of change was seen at a given site in most cases. Since a single type of adduct should be formed with these agents at a given base, this suggests that a given adduct can lead to more than one type of mutagenic change at the same sequence location. In some site specific mutation studies with hydrocarbon DNA-adducts, only a single mutagenic change in response to a given adduct has been reported so far (31, 32) . Table III lists the sequence contexts of the mutation hotspots assuming that the mutation arose at the guanine of the GC pair. At some hotspots a single type of base change was observed whereas at others, all three possible base changes were found. A substantial difference between the two bromocompounds was that only 36 of 94 total base changes were associated with a hotspot for 7-BrMeBA whereas 61 of 112 total base changes were at hotspots for 7-BrMe 12MeBA.
The relative frequency of occurrence of specific nucleotides adjacent to mutations at guanine residues is shown in Table  IV . Apparently, for either compound, a purine 3'-to a guanine favors mutation at that guanine more than a 3'-pyrimidine. On the 5'-side of a mutated guanine, another guanine is found most frequently for either compound but a thymine is less likely to be 5'-to a guanine mutated by 7-BrMeBA than by 7-BrMel2MeBA.
Comparison of Figures 3 and 4 shows that for each of the six hotspots in the 7-BrMeBA mutation spectrum, there was a polymerase arrest band present either at that site or at the 3' neighboring base. While some of these arrest bands were quite intense, others were of average or low intensity. A similar result was seen with 7-BrMe 12MeBA. At the mutation hotspot sites 109 and 123, there was extensive polymerase arrest but much less extensive arrest was associated with the remaining hotspots. Additionally, for both compounds, there were sites at which there were high levels of arrest but few or no mutations, such as 112, 142 and 181 in the 7-BrMeBA spectrum. From these data, it is clear that the site of a mutation hotspot could not be predicted from the sites of most intense polymerase arrest and recent studies indicate that different rates of repair at different nucleotides in a given sequence may be one factor that determines mutation hotspots (33) (34) (35) .
Unlike the situation with the dihydrodiol epoxides, where both cis and trans adducts can be formed, the bromo-compounds used in this study give only one kind of adduct with guanine or adenine residues in DNA (17) although additional adducts have been described in reactions with nucleosides (36) . Despite the expectation of formation of a single adduct at each purine, the mutations formed at a given site in the target gene were not always the same. G->T mutations predominated overall but G-»A and/or G-»C changes were found at sites that predominantly gave G->T changes.
The current findings also allow the effect of the 12-methyl group on the mutagenicity of 7-BrMeBA to be evaluated. The presence of the 12-methyl group was known to decrease reaction extents with DNA and to substantially decrease overall mutagenicity (37) and the latter was clearly confirmed in the present study (Table I) . This study has allowed the kinds of mutations generated by these bromo-compounds to be evaluated for the first time. Hydrocarbon dihydrodiol epoxides have occasionally generated deletion mutations in the run of GC pairs at 172-176 (6,7) but the bromo-compounds proved far more active in this regard. Though both bromo-compounds preferably generate G->T transversions (56-60% of point mutations), the presence of the 12-methyl group substantially increased (~5-fold) the fraction of G-»C transversions, decreased (~3-fold) the fraction of single base deletions (Table  IT) , and led to a substantially greater fraction of total mutations being associated with mutational hotspots (Table III) . Perhaps one of these differences is associated with the fact that, despite the greater mutagenicity of the unsubstituted compound, the 12-methyl derivative is the more potent tumorigen (23, 38) .
